Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Lipocine Inc (LPCN)

Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lipocine: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Lipocine: Q3 Earnings Snapshot

LPCN : 4.92 (+5.13%)
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference PR Newswire - Tue Sep 19, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that Dr....

LPCN : 4.92 (+5.13%)
Lipocine: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Lipocine: Q2 Earnings Snapshot

LPCN : 4.92 (+5.13%)
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2023 PR Newswire - Thu Aug 10, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced financial...

LPCN : 4.92 (+5.13%)
LPCN 1148 Phase 2 Study Meets Primary Endpoint in Patients with Cirrhosis PR Newswire - Thu Jul 27, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.92 (+5.13%)
Lipocine to Present at H.C. Wainwright Annual Neuropsychiatry Virtual Conference PR Newswire - Wed Jun 14, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.92 (+5.13%)
Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine's Oral Candidate for Rapid Relief of Depression PR Newswire - Tue May 16, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), today announced positive topline results from a pilot clinical PK bridge study of LPCN 1154 (oral brexanolone)...

LPCN : 4.92 (+5.13%)
Lipocine: Q1 Earnings Snapshot AP - Thu May 11, 2023

Lipocine: Q1 Earnings Snapshot

LPCN : 4.92 (+5.13%)
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2023 PR Newswire - Thu May 11, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.92 (+5.13%)
First Subject Dosed in the Clinical Bridge Study with Lipocine Depression Candidate, LPCN 1154 PR Newswire - Mon Apr 3, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.92 (+5.13%)

Barchart Exclusives

Up 145% YTD, Should This AI Stock Be On Your May Watchlist? Barchart - 19 minutes ago
Wall Street predicts 37% upside for this pure-play AI stock, on average. Could another strong quarter drive up the stock price? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot